Minimizing Drop Outs In Clinical Trials

Patients are an integral part of clinical trials. CRO's across the nation often face challenges in recruiting and retaining the patients throughout the clinical study and the process of patient recruitment consumes valuable time and money.

It is also understood that patient recruitment comprises 27% of overall cost of the drug development and a fact that about 80% of trials fail to meet the enrollment deadlines and only 1 in 20 patients provide valid results.

It has been identified that many patients have negative impressions about the clinical trials primarily because of lack of clarity on these trials and complicated protocols where challenges in the site coordination are the factors that hinder the process of patient recruitment and retainment.

Depending upon the trial phase, patient’s dropout rates are also estimated to range between 15 to 40 percent of enrolled patients, which causes delays in the clinical trials leading to high financial losses to the CRO's.

The patient centric approach in clinical trials is believed to improve the rate of patient retention and complete the trial successfully. In recent days, patient engagement in clinical trials has helped the CRO's communicate with their patients effectively, understand the concerns of the patients participating in clinical trials, also address the needs of patients participating in clinical trial and instill confidence in them throughout the trial process.

There are many patient engagement platforms that are available in the market, it is important to pick a solution that is comprehensive and closely aligned in meeting the objectives of clinical workflow throughout the trial which will help CRO’s establish meaningful conversation with patients and accomplish positive trial outcomes.

RippleCare provides a highly secure platform for patient engagement where it allows clinical research organizations to monitor, engage and collaborate patients throughout the clinical trial journey.

Our product comes with well-defined consent forms & patient modules to assist patient recruitment, thereby reducing the time involved in the initial phase.

A Readily Available Interactive questionnaire and comprehensive home assessment kit assists stake holders to evaluate patients much prior to their visit to the site.

Once the patient is onboarded, instantaneous two-way communication can be established between the patients and the stake holders involved in the clinical trial.

Our product is envisioned to offer meaningful engagement with patients during the process of developing drug, our workflow gives utmost importance to patient safety and patient education.

RippleCARE is a specialty driven platform, our experience in catering to multiple specialties from oncology to orthopedics helped us in understanding and arriving at an all-inclusive workflow that will cover the needs of each specialty in the most organized fashion.

Driven by the idea of artificial intelligence and automation, it lets the stake holders to focus more on their core problems related to trial over the mundane activities like record keeping and routine monitoring.

We recommend our clients to try our product, realize the value it brings to the table before signing a contract with us,

You can now leverage 30 days Free trial without sharing your credit card details.

See how Ripplecare can transform your business

SCHEDULE DEMO